首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1820495

全球 D-二聚體檢測市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及 2025 年至 2033 年預測

Global D-dimer Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年09月01日 | 出版商:

Value Market Research | 英文 165 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計 2025 年至 2033 年間，全球 D-二聚體檢測市場將以 4.58% 的顯著複合年成長率成長。到 2033 年，市場規模預計將飆升至 36.7 億美元，較 2024 年的 24.5 億美元大幅成長。

D-二聚體檢測市場因其在診斷深部靜脈栓塞、肺栓塞和瀰漫性血管內凝血等血栓性疾病中的關鍵作用而正在顯著擴張。免疫分析技術的進步，包括即時檢測 (POCT) 和高靈敏度檢測，正在提高診斷的準確性、速度和可及性。自動化分析儀和數位報告系統的整合正在簡化實驗室工作流程並提高結果的可靠性。人們對凝血障礙的認知不斷提高以及心血管疾病盛行率的不斷上升，正在推動臨床對 D-二聚體檢測的需求。

COVID-19疫情凸顯了D-二聚體檢測在評估凝血病和指導治療決策方面的重要性，進一步加速了市場成長。多重檢測平台和生物標記組的創新正在拓展診斷能力和臨床實用性。法規核准和報銷政策正在促進醫院、診斷中心和門診診所的採用。此外，攜帶式和方便用戶使用型設備的開發也使分散檢測和快速決策成為可能。

診斷公司、醫療保健提供者和研究機構之間的合作正在促進持續創新和臨床驗證。由於血栓性疾病仍然是全球重大的健康負擔，D-二聚體檢測市場有望實現強勁成長，支持及時診斷並改善患者預後。

我們的報告經過精心設計，旨在為客戶提供關於各個行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵部分，以確保客戶全面了解市場格局：

市場概況：對市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本部分探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準，將市場細分為不同的細分市場。此分析重點在於突出每個細分市場的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本部分深入分析了領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，對特定時期的市場規模和成長趨勢進行預測。這包括定量分析和圖形表示，以說明未來的市場發展軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前及新興市場趨勢、技術創新和潛在投資領域。本部分提供對未來市場發展和成長前景的洞察。

涵蓋的細分市場列表

D-二聚體測試市場報告的此部分提供了國家和地區層面的細分詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按產品

分析器
試劑和耗材

按測試類型

臨床實驗室檢查
即時檢驗

依方法

酵素連結免疫吸附試驗（ELISA）
乳膠增強免疫比濁法
螢光免疫分析
其他

按應用

深部靜脈血栓（DVT）
肺栓塞（PE）
瀰漫性血管內凝血（DIC）
其他

按最終用途

醫院
學術及研究機構
診斷中心
報告中介紹的公司列表
Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd、西門子醫療、雅培、生物梅里埃、Werfen、Horiba Ltd.、QuidelOrtho Corporation、Diazyme Laboratories、Biomedica Diagnostics、Sekisui Diagnostics。

如果您有任何客製化需求，請聯絡我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業趨勢
波特五力分析
市場吸引力分析
- 按產品進行市場吸引力分析
- 按測試類型分析市場吸引力
- 市場吸引力分析方法
- 市場吸引力分析：按應用
- 按最終用途進行的市場吸引力分析
- 市場吸引力分析：按地區

第4章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料製造商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第5章：全球 D 二聚體測試市場分析：按產品

按產品概覽
按產品進行歷史和預測資料分析
分析器
試劑和耗材

第6章：全球 D 二聚體測試市場分析：依測試類型

按測試類型概述
按測試類型分析歷史和預測數據
臨床實驗室檢查
即時檢驗

第7章：全球 D 二聚體測試市場分析：依方法

依方法概述
依方法分析歷史和預測數據
酵素連結免疫吸附試驗（ELISA）
乳膠增強免疫比濁法
螢光免疫分析
其他

第 8 章：全球 D 二聚體測試市場分析：按應用

概述：按應用
歷史和預測數據分析：按應用
深部靜脈血栓（DVT）
肺栓塞（PE）
瀰漫性血管內凝血（DIC）
其他

第9章：全球 D 二聚體測試市場分析：依最終用途

按最終用途概覽
按最終用途進行的歷史和預測數據分析
醫院
學術及研究機構
診斷中心

第 10 章：全球 D 二聚體測試市場分析：按地區

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第 11 章：D 二聚體測試公司的競爭格局

D二聚體檢測市場競爭
夥伴關係/合作/協議
併購
新產品發布
其他發展

第 12 章：公司簡介

頂級公司市佔率分析
市場集中度
Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

F. Hoffmann-La Roche Ltd

公司概況
公司收入
產品
最新動態

Siemens Healthcare

公司概況
公司收入
產品
最新動態

Abbott

公司概況
公司收入
產品
最新動態

BiomeRieux

公司概況
公司收入
產品
最新動態

Werfen

公司概況
公司收入
產品
最新動態

Horiba Ltd.

公司概況
公司收入
產品
最新動態

QuidelOrtho Corporation

公司概況
公司收入
產品
最新動態

Diazyme Laboratories

公司概況
公司收入
產品
最新動態

Biomedica Diagnostics

公司概況
公司收入
產品
最新動態

Sekisui Diagnostics

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，或者在私人公司的情況下可能不涵蓋

簡介目錄圖表

Product Code: VMR112117370

The Global D-dimer Testing market is forecasted to grow at a noteworthy CAGR of 4.58% between 2025 and 2033. By 2033, market size is expected to surge to USD 3.67 Billion, a substantial rise from the USD 2.45 Billion recorded in 2024.

The D-dimer testing market is expanding significantly due to its critical role in diagnosing thrombotic disorders such as deep vein thrombosis, pulmonary embolism, and disseminated intravascular coagulation. Advances in immunoassay technologies, including point-of-care testing (POCT) and high-sensitivity assays, are enhancing diagnostic accuracy, speed, and accessibility. The integration of automated analyzers and digital reporting systems is streamlining laboratory workflows and improving result reliability. Growing awareness of coagulation disorders and the increasing prevalence of cardiovascular diseases are driving demand for D-dimer testing in clinical settings.

The COVID-19 pandemic has underscored the importance of D-dimer testing in assessing coagulopathy and guiding treatment decisions, further accelerating market growth. Innovations in multiplex testing platforms and biomarker panels are expanding diagnostic capabilities and clinical utility. Regulatory approvals and reimbursement policies are facilitating adoption across hospitals, diagnostic centers, and outpatient clinics. Additionally, the development of portable and user-friendly devices is enabling decentralized testing and rapid decision-making.

Collaborations among diagnostic companies, healthcare providers, and research institutions are fostering continuous innovation and clinical validation. As thrombotic diseases remain a significant health burden globally, the D-dimer testing market is positioned for robust growth, supporting timely diagnosis and improved patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the D-dimer Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Analyzers
Reagents & Consumables

By Test Type

Clinical Laboratory Tests
Point-of-Care Tests

By Method

Enzyme-linked Immunosorbent Assay (ELISA)
Latex-enhanced Immunoturbidimetric Assays
Fluorescence Immunoassays
Others

By Application

Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Disseminated Intravascular Coagulation (DIC)
Others

By End Use

Hospitals
Academic & Research Institutes
Diagnostic Centers
List of Companies Profiled in the report
Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens Healthcare, Abbott, Biomerieux, Werfen, Horiba Ltd., QuidelOrtho Corporation, Diazyme Laboratories, Biomedica Diagnostics, Sekisui Diagnostics.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. D DIMER TESTING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Test Type
- 3.7.3 Market Attractiveness Analysis By Method
- 3.7.4 Market Attractiveness Analysis By Application
- 3.7.5 Market Attractiveness Analysis By End Use
- 3.7.6 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL D DIMER TESTING MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Analyzers Historic and Forecast Sales By Regions
5.4. Reagents & Consumables Historic and Forecast Sales By Regions

6. GLOBAL D DIMER TESTING MARKET ANALYSIS BY TEST TYPE

6.1. Overview By Test Type
6.2. Historical and Forecast Data Analysis By Test Type
6.3. Clinical Laboratory Tests Historic and Forecast Sales By Regions
6.4. Point-of-Care Tests Historic and Forecast Sales By Regions

7. GLOBAL D DIMER TESTING MARKET ANALYSIS BY METHOD

7.1. Overview By Method
7.2. Historical and Forecast Data Analysis By Method
7.3. Enzyme-linked Immunosorbent Assay (ELISA) Historic and Forecast Sales By Regions
7.4. Latex-enhanced Immunoturbidimetric Assays Historic and Forecast Sales By Regions
7.5. Fluorescence Immunoassays Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL D DIMER TESTING MARKET ANALYSIS BY APPLICATION

8.1. Overview By Application
8.2. Historical and Forecast Data Analysis By Application
8.3. Deep Vein Thrombosis (DVT) Historic and Forecast Sales By Regions
8.4. Pulmonary Embolism (PE) Historic and Forecast Sales By Regions
8.5. Disseminated Intravascular Coagulation (DIC) Historic and Forecast Sales By Regions
8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL D DIMER TESTING MARKET ANALYSIS BY END USE

9.1. Overview By End Use
9.2. Historical and Forecast Data Analysis By End Use
9.3. Hospitals Historic and Forecast Sales By Regions
9.4. Academic & Research Institutes Historic and Forecast Sales By Regions
9.5. Diagnostic Centers Historic and Forecast Sales By Regions

10. GLOBAL D DIMER TESTING MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1 Overview, Historic and Forecast Data Sales Analysis
- 10.3.2 North America By Segment Sales Analysis
- 10.3.3 North America By Country Sales Analysis
- 10.3.4 United States Sales Analysis
- 10.3.5 Canada Sales Analysis
- 10.3.6 Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1 Overview, Historic and Forecast Data Sales Analysis
- 10.4.2 Europe By Segment Sales Analysis
- 10.4.3 Europe By Country Sales Analysis
- 10.4.4 United Kingdom Sales Analysis
- 10.4.5 France Sales Analysis
- 10.4.6 Germany Sales Analysis
- 10.4.7 Italy Sales Analysis
- 10.4.8 Russia Sales Analysis
- 10.4.9 Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1 Overview, Historic and Forecast Data Sales Analysis
- 10.5.2 Asia Pacific By Segment Sales Analysis
- 10.5.3 Asia Pacific By Country Sales Analysis
- 10.5.4 China Sales Analysis
- 10.5.5 India Sales Analysis
- 10.5.6 Japan Sales Analysis
- 10.5.7 South Korea Sales Analysis
- 10.5.8 Australia Sales Analysis
- 10.5.9 South East Asia Sales Analysis
- 10.5.10 Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1 Overview, Historic and Forecast Data Sales Analysis
- 10.6.2 Latin America By Segment Sales Analysis
- 10.6.3 Latin America By Country Sales Analysis
- 10.6.4 Brazil Sales Analysis
- 10.6.5 Argentina Sales Analysis
- 10.6.6 Peru Sales Analysis
- 10.6.7 Chile Sales Analysis
- 10.6.8 Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1 Overview, Historic and Forecast Data Sales Analysis
- 10.7.2 Middle East & Africa By Segment Sales Analysis
- 10.7.3 Middle East & Africa By Country Sales Analysis
- 10.7.4 Saudi Arabia Sales Analysis
- 10.7.5 UAE Sales Analysis
- 10.7.6 Israel Sales Analysis
- 10.7.7 South Africa Sales Analysis
- 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE D DIMER TESTING COMPANIES

11.1. D Dimer Testing Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12. COMPANY PROFILES OF D DIMER TESTING INDUSTRY

12.1. Top Companies Market Share Analysis
12.2. Market Concentration Rate
12.3. Thermo Fisher Scientific Inc.
- 12.3.1 Company Overview
- 12.3.2 Company Revenue
- 12.3.3 Products
- 12.3.4 Recent Developments
12.4. F. Hoffmann-La Roche Ltd
- 12.4.1 Company Overview
- 12.4.2 Company Revenue
- 12.4.3 Products
- 12.4.4 Recent Developments
12.5. Siemens Healthcare
- 12.5.1 Company Overview
- 12.5.2 Company Revenue
- 12.5.3 Products
- 12.5.4 Recent Developments
12.6. Abbott
- 12.6.1 Company Overview
- 12.6.2 Company Revenue
- 12.6.3 Products
- 12.6.4 Recent Developments
12.7. BiomeRieux
- 12.7.1 Company Overview
- 12.7.2 Company Revenue
- 12.7.3 Products
- 12.7.4 Recent Developments
12.8. Werfen
- 12.8.1 Company Overview
- 12.8.2 Company Revenue
- 12.8.3 Products
- 12.8.4 Recent Developments
12.9. Horiba Ltd.
- 12.9.1 Company Overview
- 12.9.2 Company Revenue
- 12.9.3 Products
- 12.9.4 Recent Developments
12.10. QuidelOrtho Corporation
- 12.10.1 Company Overview
- 12.10.2 Company Revenue
- 12.10.3 Products
- 12.10.4 Recent Developments
12.11. Diazyme Laboratories
- 12.11.1 Company Overview
- 12.11.2 Company Revenue
- 12.11.3 Products
- 12.11.4 Recent Developments
12.12. Biomedica Diagnostics
- 12.12.1 Company Overview
- 12.12.2 Company Revenue
- 12.12.3 Products
- 12.12.4 Recent Developments
12.13. Sekisui Diagnostics
- 12.13.1 Company Overview
- 12.13.2 Company Revenue
- 12.13.3 Products
- 12.13.4 Recent Developments